Literature DB >> 3113943

Lack of cross-resistance between imipenem and other beta-lactam antibiotics for Pseudomonas aeruginosa.

W Opferkuch, W Cullmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3113943     DOI: 10.1007/bf02017634

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  9 in total

1.  Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

Authors:  J P Quinn; E J Dudek; C A DiVincenzo; D A Lucks; S A Lerner
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

Review 2.  Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future.

Authors:  C C Sanders; W E Sanders
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

3.  Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein.

Authors:  K H Büscher; W Cullmann; W Dick; W Opferkuch
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

4.  Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12.

Authors:  F Yoshimura; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

5.  [Development of resistance in imipenem therapy in Pseudomonas aeruginosa].

Authors:  T Krech; P Naumann
Journal:  Immun Infekt       Date:  1986-11

Review 6.  Review of the in vitro spectrum of activity of imipenem.

Authors:  R N Jones
Journal:  Am J Med       Date:  1985-06-07       Impact factor: 4.965

7.  [Comparative effect of beta-lactam activity on Pseudomonas aeruginosa as a function of resistance phenotypes].

Authors:  A Thabaut; A Philippon; M Meyran
Journal:  Presse Med       Date:  1984-03-29       Impact factor: 1.228

8.  Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.

Authors:  N A Curtis; R L Eisenstadt; C Rudd; A J White
Journal:  J Antimicrob Chemother       Date:  1986-01       Impact factor: 5.790

9.  Imipenem/cilastatin treatment of multiresistant Pseudomonas aeruginosa lung infection in cystic fibrosis.

Authors:  S S Pedersen; T Pressler; N Høiby; M W Bentzon; C Koch
Journal:  J Antimicrob Chemother       Date:  1985-11       Impact factor: 5.790

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.